Asymmetrical dimethylarginine inhibits shear stress-induced nitric oxide release and dilation and elicits superoxide-mediated increase in arteriolar tone

Janos Toth, Anita Racz, Pawel M. Kaminski, Michael S. Wolin, Zsolt Bagi, Akos Koller

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

l-arginine is the substrate used by NO synthase to produce the vasodilator NO. However, in several human diseases, such as hyperhomocysteinemia, diabetes mellitus, and hypertension, there is an increase in serum levels of methylated l-arginines, such as asymmetrical dimethylarginine (ADMA), which cannot be used by NO synthase to produce NO. Yet, the functional consequence of increased levels of ADMA on the vasomotor function of resistance vessels has not been delineated. We hypothesized that elevated levels of exogenous ADMA inhibit NO mediation of flow/shear stress-dependent dilation of isolated arterioles. In the presence of indomethacin, isolated arterioles from rat gracilis muscle (≈165 μm at 80 mm Hg) were incubated with ADMA (10 mol/L), which eliminated the dilations to increases in intraluminal flow (control: from 164±5.4 to 188±3.8 μm versus ADMA: from 171±6.1 to 173±6.3 μm at 20 μL/min). ADMA did not affect dilations to nifedipine (10 mol/L; control: 63.4±2%, ADMA: 65.8±3%) or 8-bromo cGMP (10 mol/L; control: 51.2±2.1%, ADMA: 49.3±3.4%). In addition, ADMA elicited significant constriction of arterioles (from 173±17 μm to 138±16 μm at 80 mm Hg), which was prevented by previous incubation of arterioles with polyethylene-glycol (PEG) superoxide dismutase (SOD; 120 U/mL, control: 155±11 μm versus ADMA: 150±14 μm). Correspondingly, ADMA increased PEG-SOD reversible manner the production of vascular superoxide assessed by lucigenin-enhanced chemiluminescence and ethidium bromide fluorescence. Thus, increased levels of ADMA in various diseases could inhibit the regulation of arteriolar resistance by shear stress-induced release of NO and elicit superoxide-mediated increase in basal tone, both of which favor the development of hypertension.

Original languageEnglish (US)
Pages (from-to)563-568
Number of pages6
JournalHypertension
Volume49
Issue number3
DOIs
StatePublished - Mar 1 2007

Fingerprint

Superoxides
Dilatation
Nitric Oxide
Arterioles
Nitric Oxide Synthase
Arginine
dimethylarginine
Hypertension
Hyperhomocysteinemia
Ethidium
Nifedipine
Luminescence
Vasodilator Agents
Constriction
Indomethacin
Blood Vessels
Diabetes Mellitus
Fluorescence

Keywords

  • ADMA
  • Arteriolar tone
  • Flow-dependent dilation
  • Nitric oxide
  • Superoxide

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Asymmetrical dimethylarginine inhibits shear stress-induced nitric oxide release and dilation and elicits superoxide-mediated increase in arteriolar tone. / Toth, Janos; Racz, Anita; Kaminski, Pawel M.; Wolin, Michael S.; Bagi, Zsolt; Koller, Akos.

In: Hypertension, Vol. 49, No. 3, 01.03.2007, p. 563-568.

Research output: Contribution to journalArticle

Toth, Janos ; Racz, Anita ; Kaminski, Pawel M. ; Wolin, Michael S. ; Bagi, Zsolt ; Koller, Akos. / Asymmetrical dimethylarginine inhibits shear stress-induced nitric oxide release and dilation and elicits superoxide-mediated increase in arteriolar tone. In: Hypertension. 2007 ; Vol. 49, No. 3. pp. 563-568.
@article{4aac0c74078249389260d6ede41fb063,
title = "Asymmetrical dimethylarginine inhibits shear stress-induced nitric oxide release and dilation and elicits superoxide-mediated increase in arteriolar tone",
abstract = "l-arginine is the substrate used by NO synthase to produce the vasodilator NO. However, in several human diseases, such as hyperhomocysteinemia, diabetes mellitus, and hypertension, there is an increase in serum levels of methylated l-arginines, such as asymmetrical dimethylarginine (ADMA), which cannot be used by NO synthase to produce NO. Yet, the functional consequence of increased levels of ADMA on the vasomotor function of resistance vessels has not been delineated. We hypothesized that elevated levels of exogenous ADMA inhibit NO mediation of flow/shear stress-dependent dilation of isolated arterioles. In the presence of indomethacin, isolated arterioles from rat gracilis muscle (≈165 μm at 80 mm Hg) were incubated with ADMA (10 mol/L), which eliminated the dilations to increases in intraluminal flow (control: from 164±5.4 to 188±3.8 μm versus ADMA: from 171±6.1 to 173±6.3 μm at 20 μL/min). ADMA did not affect dilations to nifedipine (10 mol/L; control: 63.4±2{\%}, ADMA: 65.8±3{\%}) or 8-bromo cGMP (10 mol/L; control: 51.2±2.1{\%}, ADMA: 49.3±3.4{\%}). In addition, ADMA elicited significant constriction of arterioles (from 173±17 μm to 138±16 μm at 80 mm Hg), which was prevented by previous incubation of arterioles with polyethylene-glycol (PEG) superoxide dismutase (SOD; 120 U/mL, control: 155±11 μm versus ADMA: 150±14 μm). Correspondingly, ADMA increased PEG-SOD reversible manner the production of vascular superoxide assessed by lucigenin-enhanced chemiluminescence and ethidium bromide fluorescence. Thus, increased levels of ADMA in various diseases could inhibit the regulation of arteriolar resistance by shear stress-induced release of NO and elicit superoxide-mediated increase in basal tone, both of which favor the development of hypertension.",
keywords = "ADMA, Arteriolar tone, Flow-dependent dilation, Nitric oxide, Superoxide",
author = "Janos Toth and Anita Racz and Kaminski, {Pawel M.} and Wolin, {Michael S.} and Zsolt Bagi and Akos Koller",
year = "2007",
month = "3",
day = "1",
doi = "10.1161/01.HYP.0000256764.86208.3d",
language = "English (US)",
volume = "49",
pages = "563--568",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Asymmetrical dimethylarginine inhibits shear stress-induced nitric oxide release and dilation and elicits superoxide-mediated increase in arteriolar tone

AU - Toth, Janos

AU - Racz, Anita

AU - Kaminski, Pawel M.

AU - Wolin, Michael S.

AU - Bagi, Zsolt

AU - Koller, Akos

PY - 2007/3/1

Y1 - 2007/3/1

N2 - l-arginine is the substrate used by NO synthase to produce the vasodilator NO. However, in several human diseases, such as hyperhomocysteinemia, diabetes mellitus, and hypertension, there is an increase in serum levels of methylated l-arginines, such as asymmetrical dimethylarginine (ADMA), which cannot be used by NO synthase to produce NO. Yet, the functional consequence of increased levels of ADMA on the vasomotor function of resistance vessels has not been delineated. We hypothesized that elevated levels of exogenous ADMA inhibit NO mediation of flow/shear stress-dependent dilation of isolated arterioles. In the presence of indomethacin, isolated arterioles from rat gracilis muscle (≈165 μm at 80 mm Hg) were incubated with ADMA (10 mol/L), which eliminated the dilations to increases in intraluminal flow (control: from 164±5.4 to 188±3.8 μm versus ADMA: from 171±6.1 to 173±6.3 μm at 20 μL/min). ADMA did not affect dilations to nifedipine (10 mol/L; control: 63.4±2%, ADMA: 65.8±3%) or 8-bromo cGMP (10 mol/L; control: 51.2±2.1%, ADMA: 49.3±3.4%). In addition, ADMA elicited significant constriction of arterioles (from 173±17 μm to 138±16 μm at 80 mm Hg), which was prevented by previous incubation of arterioles with polyethylene-glycol (PEG) superoxide dismutase (SOD; 120 U/mL, control: 155±11 μm versus ADMA: 150±14 μm). Correspondingly, ADMA increased PEG-SOD reversible manner the production of vascular superoxide assessed by lucigenin-enhanced chemiluminescence and ethidium bromide fluorescence. Thus, increased levels of ADMA in various diseases could inhibit the regulation of arteriolar resistance by shear stress-induced release of NO and elicit superoxide-mediated increase in basal tone, both of which favor the development of hypertension.

AB - l-arginine is the substrate used by NO synthase to produce the vasodilator NO. However, in several human diseases, such as hyperhomocysteinemia, diabetes mellitus, and hypertension, there is an increase in serum levels of methylated l-arginines, such as asymmetrical dimethylarginine (ADMA), which cannot be used by NO synthase to produce NO. Yet, the functional consequence of increased levels of ADMA on the vasomotor function of resistance vessels has not been delineated. We hypothesized that elevated levels of exogenous ADMA inhibit NO mediation of flow/shear stress-dependent dilation of isolated arterioles. In the presence of indomethacin, isolated arterioles from rat gracilis muscle (≈165 μm at 80 mm Hg) were incubated with ADMA (10 mol/L), which eliminated the dilations to increases in intraluminal flow (control: from 164±5.4 to 188±3.8 μm versus ADMA: from 171±6.1 to 173±6.3 μm at 20 μL/min). ADMA did not affect dilations to nifedipine (10 mol/L; control: 63.4±2%, ADMA: 65.8±3%) or 8-bromo cGMP (10 mol/L; control: 51.2±2.1%, ADMA: 49.3±3.4%). In addition, ADMA elicited significant constriction of arterioles (from 173±17 μm to 138±16 μm at 80 mm Hg), which was prevented by previous incubation of arterioles with polyethylene-glycol (PEG) superoxide dismutase (SOD; 120 U/mL, control: 155±11 μm versus ADMA: 150±14 μm). Correspondingly, ADMA increased PEG-SOD reversible manner the production of vascular superoxide assessed by lucigenin-enhanced chemiluminescence and ethidium bromide fluorescence. Thus, increased levels of ADMA in various diseases could inhibit the regulation of arteriolar resistance by shear stress-induced release of NO and elicit superoxide-mediated increase in basal tone, both of which favor the development of hypertension.

KW - ADMA

KW - Arteriolar tone

KW - Flow-dependent dilation

KW - Nitric oxide

KW - Superoxide

UR - http://www.scopus.com/inward/record.url?scp=33847068349&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847068349&partnerID=8YFLogxK

U2 - 10.1161/01.HYP.0000256764.86208.3d

DO - 10.1161/01.HYP.0000256764.86208.3d

M3 - Article

C2 - 17242303

AN - SCOPUS:33847068349

VL - 49

SP - 563

EP - 568

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 3

ER -